Impax Laboratories to Present at the 25th Annual Piper Jaffray Healthcare Conference on December 3

  Impax Laboratories to Present at the 25th Annual Piper Jaffray Healthcare
  Conference on December 3

Piper Jaffray Healthcare Conference 2013

Business Wire

HAYWARD, Calif. -- November 27, 2013

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that Bryan M. Reasons,
chief financial officer, and Carole S. Ben-Maimon, M.D., president of Global
Pharmaceuticals (Impax’s generics division) will present at the Piper Jaffray
Healthcare Conference on Tuesday, December 3, at 9:00 a.m. Eastern Standard
Time. The conference will be held in New York, NY.

Individuals may listen to the live or an archived presentation made at the
conference, which will be posted in the investor relations section of the
Company’s web site at www.impaxlabs.com. This presentation will be archived on
the Company’s web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug delivery
technology to the development of controlled-release and specialty generics in
addition to the development of central nervous system disorder branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through the Impax
Pharmaceuticals division. Additionally, where strategically appropriate, Impax
develops marketing partnerships to fully leverage its technology platform and
pursues partnership opportunities that offer alternative dosage form
technologies, such as injectables, nasal sprays, inhalers, patches, creams and
ointments. For more information, please visit the Company's Web site at:
www.impaxlabs.com.

Contact:

Company Contact:
Impax Laboratories, Inc.
Mark Donohue
Investor Relations and Corporate Communications
215-558-4526
www.impaxlabs.com
 
Press spacebar to pause and continue. Press esc to stop.